Erin Colgan serves as Executive at Sensei Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Erin Colgan has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 15, 2024 involved selling 3,627 shares valued at $2.9K.
Erin Colgan currently holds 67,462 shares of Sensei Biotherapeutics, Inc. (SNSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin Colgan has been a net neutral trader of SNSE stock. They have purchased $0 and sold $0 worth of shares.
Erin Colgan's most recent insider trade was on Feb 15, 2024, when they sold 3,627 shares at $0.79 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 21,300 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 30,046 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 30,046 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 21,300 | $N/A | Discretionary |
| Feb 15, 2022 | SNSE | $0 | Award | 21,000 | $N/A | Discretionary |